Taiho Oncology, Inc.
Vinayak Krishna is an experienced professional in outsourcing and vendor management, currently serving as Associate Director at Taiho Oncology, Inc. since February 2025. Prior to this role, Vinayak held positions at NOVAVAX INC, Otsuka Pharmaceutical Companies, and Johnson & Johnson, where expertise in clinical development, category management, and strategic sourcing was demonstrated. Vinayak has successfully managed significant budgets, driving performance improvements and fostering supplier relationships across various sectors. With a solid educational background including an MBA from Cranfield School of Management and diplomas from prestigious hospitality institutions, Vinayak combines skills in business management with a deep understanding of clinical operations and sourcing strategies.
This person is not in any teams
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com